Drug Database
Back to search

Belgium· BE-AMP-SAM358522-00

Lercanidipine EG 10 mg

A lercanidipine product containing lercanidipine hydrochloride hemihydrate, registered in Belgium by EG. The same ATC class is registered in 16 of our 19 countries.

ATC C08CA13

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLercanidipine EG 10 mgATCC08CA13REGISTER NO.BE-AMP-SAM358522-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lercanidipine hydrochloride hemihydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lercanidipine is registered in 16 of 19 countries.

Countries holding a registration under ATC C08CA13 (lercanidipine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose
Search lercanidipine products by name

Lercanidipine · ATC C08CA13

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lercanidipine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.14 in France to $0.36 in Switzerland — a ×2.6 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Lercanidipine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.36
  • ES Spain$0.25
  • IT Italy$0.21
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Lercanidipine Hydrochloride Hemihydrate
Manufacturer
EG
Country
Belgium (BE)
ATC code
C08CA13
ATC class
Lercanidipine
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

2 priced
  • be_apb
    2680148
    EUR 11.11
  • be_apb
    2680353
    EUR 17.15
  • be_apb
    0797175

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for lercanidipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lercanidipine against other medicinesHow interaction checks work

Lercanidipine · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lercanidipine in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lercanidipine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Germany · Lercanidipin Amarox
  • Spain · Lercanidipino Tarbis
  • United Kingdom (Northern Ireland) · Lercanidipine Hydrochloride Amarox
  • Portugal · Lercanidipina Ciclum

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/58cb7b9c-827a-4526-8176-94717737c77a
GET /v1/drugs/58cb7b9c-827a-4526-8176-94717737c77a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Lercanidipine EG 10 mg",
  "name_fr": "Lercanidipine EG 10 mg",
  "name_nl": "Lercanidipine EG 10 mg",
  "amp_code": "SAM358522-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "9.4000",
    "9.4000",
    "36.5500"
  ],
  "pack_count": 11,
  "substances": [
    "Lercanidipine Hydrochloride Hemihydrate",
    "Lercanidipine",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Lercanidipine",
  "authorisation_numbers": [
    "BE358522"
  ]
}
API referenceMCP serverPlans

See everything about lercanidipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console